Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 1
2012 5
2013 7
2014 4
2015 7
2016 8
2017 6
2018 3
2019 7
2020 6
2021 10
Text availability
Article attribute
Article type
Publication date

Search Results

57 results
Results by year
Filters applied: . Clear all
Page 1
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, Harris M, Reni M, Dowden S, Laheru D, Bahary N, Ramanathan RK, Tabernero J, Hidalgo M, Goldstein D, Van Cutsem E, Wei X, Iglesias J, Renschler MF. Von Hoff DD, et al. Among authors: ma ww. N Engl J Med. 2013 Oct 31;369(18):1691-703. doi: 10.1056/NEJMoa1304369. Epub 2013 Oct 16. N Engl J Med. 2013. PMID: 24131140 Free PMC article. Clinical Trial.
Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-analysis.
Sonbol MB, Riaz IB, Naqvi SAA, Almquist DR, Mina S, Almasri J, Shah S, Almader-Douglas D, Uson Junior PLS, Mahipal A, Ma WW, Jin Z, Mody K, Starr J, Borad MJ, Ahn DH, Murad MH, Bekaii-Saab T. Sonbol MB, et al. Among authors: ma ww. JAMA Oncol. 2020 Dec 1;6(12):e204930. doi: 10.1001/jamaoncol.2020.4930. Epub 2020 Dec 10. JAMA Oncol. 2020. PMID: 33090186 Free PMC article.
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.
Wang-Gillam A, Li CP, Bodoky G, Dean A, Shan YS, Jameson G, Macarulla T, Lee KH, Cunningham D, Blanc JF, Hubner RA, Chiu CF, Schwartsmann G, Siveke JT, Braiteh F, Moyo V, Belanger B, Dhindsa N, Bayever E, Von Hoff DD, Chen LT; NAPOLI-1 Study Group. Wang-Gillam A, et al. Lancet. 2016 Feb 6;387(10018):545-557. doi: 10.1016/S0140-6736(15)00986-1. Epub 2015 Nov 29. Lancet. 2016. PMID: 26615328 Clinical Trial.
Immunotherapy for Colorectal Cancer.
Boland PM, Ma WW. Boland PM, et al. Among authors: ma ww. Cancers (Basel). 2017 May 11;9(5):50. doi: 10.3390/cancers9050050. Cancers (Basel). 2017. PMID: 28492495 Free PMC article. Review.
Role of the Microenvironment in Gastrointestinal Tumors.
Weygant N, Ge Y, Westphalen CB, Ma WW, Vega KJ. Weygant N, et al. Among authors: ma ww. J Oncol. 2019 Dec 11;2019:2153413. doi: 10.1155/2019/2153413. eCollection 2019. J Oncol. 2019. PMID: 31885570 Free PMC article. No abstract available.
Novel adjuvant therapies for pancreatic adenocarcinoma.
Oyasiji T, Ma WW. Oyasiji T, et al. Among authors: ma ww. J Gastrointest Oncol. 2015 Aug;6(4):430-5. doi: 10.3978/j.issn.2078-6891.2015.031. J Gastrointest Oncol. 2015. PMID: 26261729 Free PMC article. Review.
The Management of Older Adults with Pancreatic Adenocarcinoma.
Ogden JR, Xie H, Ma WW, Hubbard JM. Ogden JR, et al. Among authors: ma ww. Geriatrics (Basel). 2018 Nov 26;3(4):85. doi: 10.3390/geriatrics3040085. Geriatrics (Basel). 2018. PMID: 31011120 Free PMC article. Review.
57 results